Daniel Virnich - Mar 19, 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Executive Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich
Stock symbol
TOI
Transactions as of
Mar 19, 2025
Transactions value $
-$9,122
Form type
4
Date filed
3/20/2025, 06:01 PM
Previous filing
Nov 21, 2024
Next filing
Mar 28, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Disposed to Issuer -$9.12K -10.3K -1.44% $0.89 702K Mar 19, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.